ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

53,410Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 5176

$6.39M Total Retail Price of All Prescriptions

Rank: 1 out of 5176

1,671 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,671 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 1,671 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 50,979 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$120 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 2,594 2,551 1 2
EVISTA 1,856 1,786 10 2 65
DIOVAN 1,760 1,724 10 3 19
CARVEDILOL 1,326 1,261 4 24
ALENDRONATE SODIUM 1,297 1,271 5 18
FORTEO 1,168 1,105 10 6 264
SIMVASTATIN 1,138 1,080 7 1
LOSARTAN POTASSIUM 1,136 1,095 8 14
SINGULAIR 954 939 10 9 62
ATELVIA 952 942 10 146
EXELON 932 905 11 162
LIDODERM 872 855 12 59
ATENOLOL 818 801 13 12
TAMSULOSIN HCL 762 731 14 20
METFORMIN HCL 736 692 15 7
LEVOTHYROXINE SODIUM 690 657 16 4
JANUVIA 671 617 17 25
LISINOPRIL 649 604 18 5
NIFEDIPINE ER 647 625 19 48
TRILIPIX 632 615 10 20 187
COLCRYS 614 592 10 21 170
CRESTOR 559 508 22 15
BYSTOLIC 549 518 23 96
ALLOPURINOL 545 532 24 41
BISOPROLOL-HYDROCHLOROTHIAZIDE 542 524 25 164
MONTELUKAST SODIUM 515 504 10 26 123
DIOVAN HCT 512 493 27 39
SYNTHROID 502 475 28 33
AMMONIUM LACTATE 485 471 29 91
JANUMET 472 456 30 77
NEXIUM 466 446 31 16
OMEPRAZOLE 446 420 32 3
PLAVIX 429 411 33 29
BENICAR 421 402 34 100
ZOSTAVAX 409 400 35 219
GLIMEPIRIDE 395 384 36 37
CLOPIDOGREL 394 381 37 26
AVODART 391 391 38 107
ZOLPIDEM TARTRATE 377 357 39 17
DULERA 375 365 10 40 429
LOSARTAN-HYDROCHLOROTHIAZIDE 367 353 41 35
GLIPIZIDE XL 367 351 41 83
NAMENDA 367 357 41 47
VOLTAREN 343 327 44 97
MELOXICAM 338 316 45 53
WELCHOL 333 307 10 46 230
DONEPEZIL HCL 326 322 47 28
CLOBETASOL PROPIONATE 307 294 48 130
LIDOCAINE 294 281 49 179
PROAIR HFA 285 278 50 60
ATORVASTATIN CALCIUM 284 277 51 9
FINASTERIDE 279 268 52 69
FLUOCINONIDE 278 262 53 165
ADVAIR DISKUS 275 267 54 32
MEGESTROL ACETATE 274 273 R 55 263
PEN NEEDLE 274 251 55 144
AZITHROMYCIN 273 251 57 42
ISOSORBIDE MONONITRATE ER 273 270 57 44
NATEGLINIDE 271 257 10 59 272
ALCOHOL PREP PADS 264 245 10 60 198
ACTOS 262 250 61 85
PATANOL 259 252 62 158
DILTIAZEM 24HR CD 257 245 63 119
CARBIDOPA-LEVODOPA 251 243 64 98
LOVAZA 248 236 65 43
CYMBALTA 243 233 66 90
RANITIDINE HCL 232 210 67 36
METOPROLOL SUCCINATE 225 223 68 11
MICARDIS 225 224 68 154
METOPROLOL TARTRATE 222 201 70 6
HYDRALAZINE HCL 222 214 70 73
MECLIZINE HCL 218 214 72 81
GEMFIBROZIL 216 199 73 139
GLYBURIDE-METFORMIN HCL 213 197 R 74 76
FENOFIBRATE 212 200 75 102
CELEBREX 209 195 76 80
IBUPROFEN 202 185 77 72
VIREAD 202 145 77 250
SPIRIVA 195 195 79 54
DOXAZOSIN MESYLATE 194 194 80 103
ROPINIROLE HCL 192 191 81 208
PROCTOZONE-HC 187 177 82 171
LIPITOR 187 186 82 51
ENALAPRIL MALEATE 186 168 84 22
NASONEX 183 167 85 178
ZETIA 183 173 85 68
PATADAY 174 164 87 220
DIGOXIN 174 168 87 56
LANTUS SOLOSTAR 167 161 89 70
ALCOHOL SWABS 164 144 90 115
TRIAMCINOLONE ACETONIDE 161 146 91 125
PRADAXA 159 153 92 192
DICYCLOMINE HCL 159 154 92 224
GABAPENTIN 151 131 94 21
FLUOCINONIDE-E 150 144 10 95 505
PREDNISONE 149 128 96 52
DIPYRIDAMOLE 142 142 R 97 512
COMBIVENT 140 128 98 156
FLECTOR 140 137 98 282
MICARDIS HCT 138 138 100 180
VENTOLIN HFA 137 132 101 64
MEGACE ES 136 135 R 102 423
PIOGLITAZONE HCL 135 132 R 103 237
HYDROCHLOROTHIAZIDE 135 133 103 10
FUROSEMIDE 129 114 105 8
BENICAR HCT 129 126 105 110
SINGLE USE SWAB 127 119 107 108
HYDROCORTISONE 124 119 108 265
AGGRENOX 124 122 108 235
LACTULOSE 123 108 110 87
FLUTICASONE PROPIONATE 122 114 111 38
ONGLYZA 119 117 112 153
SYMBICORT 119 118 112 120
SOLARAZE 117 110 114 157
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 112 115 49
GLYBURIDE 110 110 R 116 67
CIPROFLOXACIN HCL 109 101 117 84
UNIFINE PENTIPS 109 101 117 261
CIMETIDINE 108 107 119 604
PAROXETINE HCL 107 104 120 93
GLIPIZIDE ER 106 102 121 117
GLIPIZIDE 100 94 122 63
LYRICA 97 86 123 133
HYDROXYZINE HCL 93 90 R 124 213
AMITIZA 92 90 125 197
MUPIROCIN 84 78 126 182
TEKTURNA 84 83 126 255
CHLORHEXIDINE GLUCONATE 78 75 128 202
BONIVA 73 70 129 236
SPIRONOLACTONE 72 62 130 88
VICTOZA 2-PAK 71 71 131 517
DEXILANT 70 70 132 118
CALCITRIOL 69 57 133 261
SERTRALINE HCL 66 66 134 30
ACTONEL 66 66 134 134
FAMOTIDINE 65 64 136 58
RESTASIS 65 62 136 353
CLOTRIMAZOLE-BETAMETHASONE 64 64 138 94
PRISTIQ ER 64 63 138 478
EXFORGE 63 63 140 126
PROLIA 63 62 140 448
RIVASTIGMINE 62 62 142 364
LABETALOL HCL 61 60 143 114
VALSARTAN-HYDROCHLOROTHIAZIDE 61 55 143 292
ULORIC 58 58 145 280
ENABLEX 57 57 146 284
BARACLUDE 57 40 146 373
ZOVIRAX 56 51 148 313
VESICARE 56 56 148 210
PROPYLTHIOURACIL 56 51 148 607
AMIODARONE HCL 55 55 151 281
FLUOCINONIDE EMOLLIENT 55 52 10 151 695
AZOR 55 55 151 194
AMOXICILLIN 52 48 154 163
LEVEMIR FLEXPEN 50 35 155 200
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.